Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000217733 | SCV000272884 | uncertain significance | not specified | 2016-01-15 | criteria provided, single submitter | clinical testing | The p.Arg3522Gly variant in USH2A has not been previously reported in individual s with hearing loss or Usher syndrome, but has been identified 11/66536 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitu te.org; dbSNP rs147374057). Although this variant has been seen in the general p opulation, its frequency is not high enough to rule out a pathogenic role. Compu tational prediction tools and conservation analyses suggest that the p.Arg3522Gl y variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, the clinical significance of t he p.Arg3522Gly variant is uncertain. |
Fulgent Genetics, |
RCV000763829 | SCV000894747 | uncertain significance | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001453428 | SCV001657121 | likely benign | not provided | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001274951 | SCV001459535 | uncertain significance | Usher syndrome type 2A | 2019-11-06 | no assertion criteria provided | clinical testing |